Close
  • Home

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

Type 1 Diabetes

Commercial  ·  Type 1 Diabetes
Adocia filed patent for β-cell therapy scaffold in T1D

Type 1 Diabetes – January 2021 Type 1 Diabetes – January 2021 Adocia files patent for its innovative hydrogel scaffold cell therapy for the treatment of Type 1 Diabetes 11 Jan 2020 Hydrogel scaffold (β-cell therapy) – Adocia Adocia has […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Type 1 Diabetes
Tidepool’s automated insulin dosing app for management of T1D filed with FDA

Type 1 Diabetes – January 2021 Type 1 Diabetes – January 2021 Tidepool completes FDA submission of Tidepool Loop an automated insulin dosing app for management of Type 1 Diabetes (T1D) 07 Jan 2021 Tidepool Loop (automated insulin dosing app) […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Type 1 Diabetes
REMD Biotherapeutics’ Volagidemab T1D Phase 2 positive top-line results reported

Type 1 Diabetes – January 2021 Type 1 Diabetes – January 2021 REMD Biotherapeutics announced completion of enrollment and top-line results from Phase 2 trial of Volagidemab in patients with Type 1 Diabetes 07 Jan 2021 Volagidemab/ REMD-477 (Human IgG2 […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Type 1 Diabetes
BLA filed for Provention Bio’s Teplizumab for T1D

Type 1 Diabetes – January 2021 Type 1 Diabetes – January 2021 Provention Bio announced U.S. FDA filing of a biologics license application (BLA) and priority review for Teplizumab for the delay or prevention of clinical Type 1 Diabetes in […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Type 1 Diabetes
T-cell protein a target for prevention of Type 1 Diabetes

Type 1 Diabetes – January 2021 Type 1 Diabetes – January 2021 Preclinical results in mice targeting transcriptional coregulator OCA-B/Pou2af1 and its effect on Type 1 Diabetes 09 Dec 2020 Objective: To assess if T cell-specific OCA-B deletion and pharmacologic […]

by Sandhya Ramalingam

Continue Reading


Contact:

  info@ciscientists.com

 +1-908-212-7484

Optimal Dose

For a subscription, please provide your email id